Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
November 18, 2024 10:23 ET
|
Spartan Capital Securities, LLC
New York, NY, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a leading investment banking firm, is pleased to announce its role as the sole placement agent in Virpax...
Top Wealth Group Holding Limited Announces Pricing of $10.8 Million Public Offering of Ordinary Shares
October 11, 2024 09:00 ET
|
Top Wealth Group Holding Ltd
Hong Kong, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Top Wealth Group Holding Limited (NASDAQ: TWG) (“Top Wealth” or the “Company”), a Hong Kong-based supplier of luxury caviar products, today announced the...
Spartan Capital Securities Announces Successful Closing of Siyata Mobile Inc.’s $4.0 Million Public Offering of Common Shares and Pre-Funded Warrants
August 19, 2024 11:00 ET
|
Spartan Capital Securities, LLC
NEW YORK, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities LLC, a premier investment banking firm, is thrilled to announce the successful closing of Siyata Mobile Inc.’s public...
Eureka Acquisition Corp Announces Closing of $50 Million Initial Public Offering
July 03, 2024 13:31 ET
|
Eureka Acquisition Corp
Shanghai, July 03, 2024 (GLOBE NEWSWIRE) -- Eureka Acquisition Corp (the “Company”), a blank check company incorporated as a Cayman Islands exempted company today announced the closing of its...
Beamr Imaging Ltd. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares
February 15, 2024 16:15 ET
|
Beamr Imaging Ltd.
Herzliya, Israel, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (Nasdaq: BMR) (“Beamr” or the “Company”), a leader in video optimization technology, today announced the closing of its...
Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering
September 14, 2023 09:23 ET
|
Clearmind Medicine Inc.
Tel Aviv, Israel / Vancouver, Canada, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a biotech company focused on the discovery and...